Literature DB >> 22705337

Primary or secondary prevention for AD: who cares?

Giovanni B Frisoni, John Q Trojanowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22705337      PMCID： PMC4533993          DOI： 10.1016/S1474-4422(12)70143-6

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  5 in total

1.  Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Colombia at the centre of preclinical AD research.

Authors: 
Journal:  Lancet Neurol       Date:  2012-07       Impact factor: 44.182

Review 3.  Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets.

Authors:  Virginia M-Y Lee; Kurt R Brunden; Michael Hutton; John Q Trojanowski
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

4.  The topography of grey matter involvement in early and late onset Alzheimer's disease.

Authors:  Giovanni B Frisoni; Michela Pievani; Cristina Testa; Francesca Sabattoli; Lorena Bresciani; Matteo Bonetti; Alberto Beltramello; Kiralee M Hayashi; Arthur W Toga; Paul M Thompson
Journal:  Brain       Date:  2007-02-09       Impact factor: 13.501

5.  Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees.

Authors:  William E Klunk; Julie C Price; Chester A Mathis; Nicholas D Tsopelas; Brian J Lopresti; Scott K Ziolko; Wenzhu Bi; Jessica A Hoge; Ann D Cohen; Milos D Ikonomovic; Judith A Saxton; Beth E Snitz; Daniel A Pollen; Majaz Moonis; Carol F Lippa; Joan M Swearer; Keith A Johnson; Dorene M Rentz; Alan J Fischman; Howard J Aizenstein; Steven T DeKosky
Journal:  J Neurosci       Date:  2007-06-06       Impact factor: 6.167
  5 in total
  1 in total

1.  Women with the Alzheimer's risk marker ApoE4 lose Aβ-specific CD4⁺ T cells 10-20 years before men.

Authors:  A N Begum; C Cunha; H Sidhu; T Alkam; J Scolnick; E R Rosario; D W Ethell
Journal:  Transl Psychiatry       Date:  2014-07-29       Impact factor: 6.222
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.